Institution
University of Illinois Chicago
Also known as: University of Illinois at Chicago · University of Illinois at Chicago Circle · Université de l'illinois à chicago · UIC
- 120running trials
- 68closed trials
- 184,494publications (OpenAlex)
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Physical Activity Intervention for Individuals Newly Diagnosed With MS
Not yet recruiting
Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)
Recruiting
Recruiting
Not yet recruiting
Behavioral Intervention for Lifestyle Physical Activity in Parkinson's Disease
Recruiting
Integrating MOUD in Nonmedical Community Settings (Better Together)
Enrolling by invitation
Recruiting
Recruiting
The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk
Recruiting
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Recruiting
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Recruiting
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
Recruiting
Recruiting
Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females
Recruiting
Recruiting
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
Recruiting
Recruiting
Home Based Functional Balance Intervention for Multiple Sclerosis
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Active, not recruiting
Active, not recruiting
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
Recruiting
Recruiting
Active, not recruiting
Recruiting
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
Recruiting
Recruiting
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Recruiting
Recruiting
Recruiting
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Active, not recruiting
Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
Showing 50 of 120.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer8 recruiting
- Stroke8 recruiting
- Multiple sclerosis6 recruiting
- Obesity6 recruiting
- Sickle cell disease6 recruiting
- HIV5 recruiting
- Type 1 diabetes5 recruiting
- Type 2 diabetes4 recruiting
- Multiple myeloma3 recruiting
- Parkinson disease3 recruiting
- Prostate cancer3 recruiting
- Atrial fibrillation2 recruiting
- Childhood cancers2 recruiting
- Chronic kidney disease2 recruiting
- COPD2 recruiting
- Diffuse large B-cell lymphoma2 recruiting
- Head and neck cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Mild cognitive impairment2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- ALS (motor neurone disease)1 recruiting
- Aplastic anaemia1 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Coronary artery disease1 recruiting
- Depression1 recruiting
- Diabetic eye disease1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Follicular lymphoma1 recruiting
- Hodgkin lymphoma1 recruiting
- IgA nephropathy1 recruiting
- Insomnia1 recruiting
- Iron deficiency anaemia1 recruiting
- Macular degeneration1 recruiting
- Optic neuritis1 recruiting
- Osteonecrosis (avascular necrosis)1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
Terminated
Treadmill Perturbation Training for Fall Prevention After Total Knee Replacement
Completed
Terminated
Effect of Continuing Versus Holding Metformin During Hospitalizations.
Completed
Completed
Completed
Completed
Targeting Chronic Stress for Reducing Risk Factors for Colorectal Cancer
Completed
Motor and Neurophysiological Changes After Ischemic Conditioning in Individuals With Stroke
Terminated
Feasibility of Remote Exercise Training for Hispanics/Latinos With MS
Completed
Pilot Trial to Evaluate PROblem Solving Therapy and APPLE Watch for College Students
Completed
Completed
Completed
Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors
Completed
Completed
Completed
Completed
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
Completed
Self-regulation for Older Adults With Asthma Through Remote Education
Completed
Preparing a Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control
Completed
Completed
Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence
Completed
Completed
Withdrawn
Impact of Obesity on the Pharmacokinetics of Imipenem-Relebactam in ICU Patients
Withdrawn
A Safety Study of Brentuximab Vedotin in Participants With HIV
Completed
Completed
Completed
Perioperative Nutritional Optimization in Head and Neck Cancer Patients
Completed
Feasibility Testing a Meditation App for Youth in the Legal System
Completed
Completed
Completed
Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy
Completed
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir
Completed
Completed
Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)
Completed
Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome
Completed
Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline
Recruiting
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
Completed
Fibromyalgia TENS in Physical Therapy Study (TIPS): an Embedded Pragmatic Clinical Trial
Completed
Sleep Optimization to Improve Glycemic Control in Adults With Type 1 Diabetes
Completed
Completed
HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis
Completed
Completed
Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)
Terminated
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
Completed
An Avatar-based Mobile Phone Intervention to Promote Health in African American MSM
Completed
Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)
Completed
Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial
Completed
Showing 50 of 68.
Registry name variants (17)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
University of Illinois at Chicago
Chicago, Illinois 60612
117 trials
University of Illinois Chicago
Chicago, Illinois 60612
54 trials
University Illinois Chicago
Chicago, Illinois 60607
3 trials
NCT07510048Combatting HIV Or Other STIs Early (CHOOSE)
Contact: Rachel Jackson
NCT06738407Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Contact: Rachel Jackson
NCT04483206Personalized Autologous Transplant for Multiple Myeloma
Contact: Karen Sweiss, PharmD
University of Illinois at Chicago College of Medicine
Chicago, Illinois 60612
2 trials
Applied Health Sciences Building - University of Illinois at Chicago
Chicago, Illinois 60612
1 trial
Biomechanics and Clinical Outcomes Laboratory, University of Illinois Chicago
Chicago, Illinois 60612
1 trial
University of Illinois at Chicago
Chicago, Illinois 60607
1 trial
University of Illinois at Chicago
Chicago, Illinois 60607
1 trial
University of Illinois at Chicago
Chicago, Illinois 60607
1 trial
University of Illinois at Chicago (Site 0061)
Chicago, Illinois 60612
1 trial
University of Illinois at Chicago (Site 0105)
Chicago, Illinois 60612
1 trial
NCT06136624Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Contact: Study Coordinator
University of Illinois at Chicago- Site Number : 8400003
Chicago, Illinois 60607
1 trial
University of Illinois-Chicago - College of Medicine- Site Number : 8400007
Chicago, Illinois 60612
1 trial
University of Illinois-Chicago - College of Medicine- Site Number : 8400054
Chicago, Illinois 60612
1 trial
University of Illinois-Chicago - College of Medicine- Site Number : 8400055
Chicago, Illinois 60612
1 trial
University of Illinois - Chicago
Chicago, Illinois 60607
1 trial
University of Illinois Chicago (Site 0027)
Chicago, Illinois 60612
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Obesity148 works · 17 trials
- HIV121 works · 15 trials
- Alzheimer disease93 works · 0 trials
- Chronic kidney disease76 works · 4 trials
- Type 2 diabetes67 works · 6 trials
- Multiple sclerosis65 works · 12 trials
- Melanoma52 works · 3 trials
- Prostate cancer51 works · 5 trials
- Sickle cell disease44 works · 14 trials
- Diabetic eye disease30 works · 2 trials
- Mild cognitive impairment29 works · 2 trials
- Glaucoma28 works · 0 trials
- Obstructive sleep apnoea26 works · 0 trials
- Cervical cancer26 works · 2 trials
- COPD25 works · 5 trials
- Type 1 diabetes22 works · 7 trials
- Long COVID and ME/CFS19 works · 5 trials
- Hypertrophic cardiomyopathy17 works · 0 trials
- Atopic dermatitis (eczema)17 works · 0 trials
- Peripheral artery disease14 works · 0 trials
- Head and neck cancer14 works · 4 trials
- Macular degeneration11 works · 2 trials
- Down syndrome11 works · 0 trials
- Pulmonary arterial hypertension11 works · 0 trials
- Hidradenitis suppurativa10 works · 0 trials
- Ventricular tachycardia9 works · 0 trials
- Sarcoidosis8 works · 0 trials
- Fibromyalgia5 works · 1 trial
- Vitiligo4 works · 0 trials
- Keratoconus4 works · 0 trials
Institution data: ROR 02mpq6x41 (CC0-1.0)Updated 15 Nov 2026